Home
Portfolio
Strategy
Team
News
Contact
Investor Login
Home
Portfolio
Strategy
Team
News
Contact
Pear Therapeutics and PreferredOne Announce Broad Based Patient Access and Reimbursement for reSET® and reSET-O® for People with Substance Use Disorder and Opioid Use Disorder
Read Article
News
2020
2019
Archive
July 22, 2020
Homology Medicines Appoints Jeff Poulton to the Board of Directors
July 17, 2020
Vor Biopharma Appoints Daniella Beckman to its Board of Directors
July 17, 2020
IDEAYA Announces IDE196 Program Update and Clinical Protocol Criteria Met for Cohort Expansion in Skin Melanoma for Phase 2 GNAQ/11 Basket Trial
July 16, 2020
RareCyte® Announces the Orion™ Spatial Biology Platform with Breakthrough Technology for Same-Day Highly Multiplexed Tissue Analysis
July 16, 2020
Aprea Therapeutics Announces Expansion of Clinical Trial Evaluating Eprenetapopt for the Front-Line Treatment of TP53 Mutant Acute Myeloid Leukemia (AML)
July 15, 2020
Vor Biopharma Appoints Dr. Christopher Slapak as Chief Medical Officer
July 14, 2020
Pear Therapeutics Announces First Participant Enrolled in Virtual Real-World Study of Adults with Chronic Insomnia
July 10, 2020
IDEAYA Biosciences Doses First Patient in a Phase 1 Combination Study of IDE196 and Binimetinib, a MEK Inhibitor
July 7, 2020
Cabaletta Bio and Artisan Bio Announce Gene Editing Research and Collaboration Agreement to Develop Next-Generation CAAR T Cell Therapies
July 7, 2020
Pear Therapeutics Announces $50 Million Credit Facility From Perceptive Advisors
« Previous Page
1
2
3
4
5
…
67
Next Page »
